methylphenidate

(redirected from Adhd patch)
Also found in: Dictionary, Thesaurus.
Related to Adhd patch: Vyvanse

methylphenidate

 [meth″il-fenĭ-dāt]
a mild central nervous system stimulant; the hydrochloride salt is administered orally in the treatment of attention-deficit/hyperactivity disorder and narcolepsy.

methylphenidate

/meth·yl·phen·i·date/ (meth″il-fen´ĭ-dāt) a central stimulant, used in the form of the hydrochloride salt in the treatment of attention-deficit in children and narcolepsy.

methylphenidate

(mĕth′əl-fĕn′ĭ-dāt′, -fē′nĭ-)
n.
A drug, C14H19NO2, chemically related to amphetamine, that acts as a mild stimulant of the central nervous system and is used in its hydrochloride form to treat attention deficit hyperactivity disorder and narcolepsy.

methylphenidate

An amphetamine-derived CNS stimulant.
 
Adverse effects
Decreased appetite—10–15% of children have major weight loss; insomnia—most suffer sleep delay; abdominal pain; headaches; dry mouth; dizziness; depression, tachycardia; a proposed link to decreased growth is uncertain.
 
Indications for
Hyperactivity, ADD, childhood narcolepsy.

methylphenidate

Ritalin® Neuropharmacology An amphetamine derived CNS stimulant used to control ADD and hyperactivity in children Adverse effects ↓ Appetite, 10-15% of children have major weight loss; insomnia–most suffer sleep delay, abdominal pain, headaches, dry mouth, dizziness, depression, tachycardia; link with ↓ growth is uncertain Used for Hyperactivity; narcolepsy; ADD. See Amphetamine.

methylphenidate

A nervous system stimulant drug that, paradoxically, has been found effective in the management of ATTENTION-DEFICIT HYPERACTIVITY DISORDER in children. A brand name is Ritalin. The current consensus of opinion on the use of this drug for this purpose is that it is grossly over-prescribed, especially in the USA.

methylphenidate

a central nervous system stimulant used in the treatment of hyperkinesis and narcolepsy in dogs.
References in periodicals archive ?
The approval and launch of this first-of-its-kind ADHD patch diversified our sources of revenue, increased our cash and short-term investments to over $150 million, and contributed to significant growth in our top and bottom lines.
PHILADELPHIA, March 20 /PRNewswire-FirstCall/ -- Shire plc , the global specialty biopharmaceutical company, announced today a voluntary market withdrawal/recall of thirty-nine (39) lots of the ADHD patch DAYTRANA (the lots of DAYTRANA patches affected by this action are listed below).
Since the effect of the medication in DAYTRANA starts to decrease upon patch removal, the ADHD patch allows parents, at the direction of the physician, to vary the duration of effect of the medication up to the recommended nine-hour wear time," said Oscar Bukstein, associate professor of psychiatry, University of Pittsburgh School of Medicine.
During the next 12 months, what is the likelihood physicians will prescribe or recommend Daytrana, the ADHD patch from Shire Pharmaceuticals, for children with ADHD?